Beta Bionics, Inc.
BBNX
$10.65
-$0.31-2.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 144.79% | 440.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 144.79% | 440.09% | |||
| Cost of Revenue | 166.15% | 317.08% | |||
| Gross Profit | 130.92% | 627.67% | |||
| SG&A Expenses | 72.95% | 139.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 100.26% | 133.11% | |||
| Operating Income | -55.81% | -24.99% | |||
| Income Before Tax | 3.93% | -12.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.93% | -12.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.93% | -12.17% | |||
| EBIT | -55.81% | -24.99% | |||
| EBITDA | -58.58% | -25.97% | |||
| EPS Basic | 13.12% | 9.35% | |||
| Normalized Basic EPS | 13.12% | 9.35% | |||
| EPS Diluted | 13.12% | 9.35% | |||
| Normalized Diluted EPS | 13.12% | 9.35% | |||
| Average Basic Shares Outstanding | 10.59% | 23.74% | |||
| Average Diluted Shares Outstanding | 10.59% | 23.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||